By Alan G E Wilson (ed.)
Drug metabolism, pharmacokinetics and toxicokinetics as determinants of drug attrition and the protection of xenobiotics are seriously vital. This publication provides a complete treatise at the present concerns and demanding situations dealing with drug metabolism and pharmacokinetics. Readers will discover a thorough exploration in their predictive function in impacting drug discovery and improvement and in enhancing the luck fee and security overview of prescription drugs and commercial or occupational chemical compounds. Chapters not just concentrate on the present kingdom of artwork, with special examples, yet on destiny wishes and ways more likely to enhance our prediction of capability human chance.
Discussions of serious houses which are determinants of a compound’s metabolic and pharmacokinetic destiny keep on with introductory chapters. The Drug Discovery procedure more and more comprises pharmacokinetics and drug metabolism screening and concentration has shifted in the direction of in silico, computational and structures biology ways. center chapters replicate this and the new curiosity and wish to evaluate the position of transporters, in addition to drug metabolizing enzymes, as strength determinants of pharmacokinetic behaviour, toxicity and drug-drug interactions. finally, chapters disguise the problems and components enthusiastic about translating pharmacokinetics from in silico to in vivo and from animal versions to guy, and postulate destiny instructions and opportunities.
Leading specialists from academia, and regulatory our bodies around the globe give a contribution their wisdom to this e-book, which scientists focused on many facets of the drug discovery procedure, in addition to regulators and postgraduate scholars, will discover a resource
Read or Download New Horizons in Predictive Drug Metabolism and Pharmacokinetics PDF
Best pharmacology books
Enzyme Technologies for Pharmaceutical and Biotechnological Applications
Eli Lily and corporate, Greenfield, identity. Reference offering an up to date evaluate of enzyme features in human and animal wellbeing and fitness, together with assurance of recent and rising applied sciences in biotechnical and pharmaceutical industries. Emphasizes glossy equipment of metabolic engineering and drug discovery approaches, and information enzymes on the topic of human sickness.
Clinician's Pocket Drug Reference 2009
Must-know information regarding a thousand of the main conventional medictions -- at your fingertips and able to use! compliment for a prior variation: "This is a really precious and up to date pocket reference for universal drugs. five Stars! "--Doody's evaluate carrier Why spend time plowing via details you don't want while what you actually need to grasp is true the following in a single concise consultant?
Warfarin - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
It is a 3-in-1 reference booklet. It supplies a whole scientific dictionary masking 1000s of phrases and expressions on the subject of warfarin. It additionally provides huge lists of bibliographic citations. eventually, it offers details to clients on the right way to replace their wisdom utilizing quite a few web assets.
- New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients
- Pharmacology of Intestinal Permeation I
- The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead
- Pharmacology and Therapeutics of Cough
- Drug Delivery Systems
- Drug Discovery: From Bedside to Wall Street
Additional info for New Horizons in Predictive Drug Metabolism and Pharmacokinetics
Example text
Jonker and A. H. Schinkel, J. Pharmacol. Exp. , 2004, 308, 2. G. Englund, F. Rorsman, A. Ronnblom, U. Karlbom, L. Lazorova, J. Grasjo, A. Kindmark and P. Artursson, Eur. J. Pharm. , 2006, 29, 269–277. C. Hilgendorf, G. Ahlin, A. Seithel, P. Artursson, A. L. Ungell and J. Karlsson, Drug Metab. , 2007, 35, 1333. K. M. Giacomini, S. M. Huang, D. J. Tweedie, L. Z. Benet, K. L. Brouwer, X. Chu, A. Dahlin, R. Evers, V. Fischer, K. M. Hillgren, K. A. Hoffmaster, T. Ishikawa, D. Keppler, R. B. Kim, C.
Homolya, Z. Hollo, U. A. Germann, I. Pastan, M. M. Gottesman and B. Sarkadi, J. Biol. , 1993, 268, 21493–21496. A. B. Shapiro, A. B. Corder and V. Ling, Eur. J. , 1997, 250, 115. B. L. Shneider, Pediatr. , 2004, 8, 609. P. Matsson, J. M. Pedersen, U. Norinder, C. A. S. Bergström and P. Artursson, Pharm. , 2009, 26, 1816. J. M. Pedersen, P. Matsson, C. A. S. Bergström, J. Hoogstraate, A. Noren, E. L. LeCluyse and P. Artursson, Toxicol. , 2013, 136, 328. M. Karlgren, A. Vildhede, U. Norinder, J.
Recent developments in sophisticated crystallization methods, and utilization of polymeric and surfactant stabilizers make it technically feasible to produce particles in the order of a few hundred nanometers. Nanoparticles comprise polymeric, liposomal, or solid lipid formulated nanoscale drug assemblies, and also include nanosized drug crystals and suspensions. Drug nanoparticles drastically increase the ratio of surface area to mass compared with simple drug powders, and have the potential to provide significant increases in the rate of dissolution.
